Medicine shouldn’t just be cheap; it should be accessible

The new guidelines the Patented Medicine Prices Review Board will use to determine whether the price of a new medication is acceptable or too high are so unclear that both pharmaceutical companies and patients’ rights groups are united in their criticism of them.

Service matters most in health care

Ford’s plan to involve privately owned and operated facilities in delivering care within Ontario’s universal health system builds on well-documented success stories.

Back to top